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Abstract 
New Zealand has undergone a period of previously unprecedented change to the community 
pharmacy sector. A new funding model was implemented in 2012 with the goal of rewarding 
pharmacists for patient contact and clinical input, rather than solely for the number of medicines 
dispensed. The change has been immensely challenging for pharmacy, as they have coped with 
funding and service model changes. 
The new funding model saw the introduction of the Long Term Conditions (LTC) pharmacy service. 
The LTC service is designed for people with complex health and medicines management needs and 
medicine adherence issues. Patients in the LTC service receive more frequent dispensing, along with 
adherence reminders and increased pharmacist support. The pharmacy receives a monthly fee for 
this additional work, and is required to complete ongoing and time consuming paperwork.  
There is a lack of awareness about the actual cost to pharmacy of providing the LTC service as there 
is an absence of any studies that have attempted to define the resources needed to deliver the 
service and the activities that drive these costs. The aim of this report is to define the actual cost to 
pharmacy of delivering the LTC service through the lens of Activity Based Management (ABM), and 
define cost drivers using a time driven activity based costing system (TDABC).  
Research Method 
Primary data was collected through a semi-structured survey and 18 responses were elicited from 
participating pharmacies. TDABC was employed to estimate the cost of providing the LTC service.  
Findings  
Results indicate that the monthly payment of $20.80 per LTC patient registered is insufficient to 
cover ongoing costs. In addition to ongoing monthly costs, pharmacies incur one-off costs to initiate 
a new patient into the LTC service.  One off costs show a positive relationship with ongoing costs and 
wide variation is observed for costs between pharmacies. The major cost driver was identified as 
pharmacist time.  
Recommendations 
Future studies should examine the processual variations in pharmacies with low-cost and high cost 
profiles with the aim of providing pharmacists with more efficient options for delivering the service. 
Greater utilisation of software through automation of patient eligibility and administrative tasks 
could help free up pharmacist time. 
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Introduction 
 
Community pharmacies in New Zealand are small to medium sized businesses which supply 
medications and associated health products and provide health-related services to the public 
(Horsfield, Kelly, Sheridan, Stewart, & Clark, 2014). Considering the prevailing number of pharmacies 
and their presence in communities of varying demographics, size and location, their extended hours 
of operation, and their walk-in character, they have an important role in improving access to quality 
primary health care (Zolezzi, Bye, Harrison, Tsuyuki, & Shaw, 2014).  
In New Zealand, a range of community pharmacy services are publicly funded by District Health 
Boards (DHB) through an agreement with community pharmacies known as the Community 
Pharmacy Services Agreement (CPSA) (Shirtcliffe, 2014). This national agreement between 
community pharmacies and their local DHBs’, sanctioned in 2012, represents the biggest change to 
how pharmacy services are funded in more than 70 years (District Health Boards, 2012). It sets out a 
funding model for pharmacy services based on a patient-centred approach, rather than the previous 
reimbursement per dispensing model (Zolezzi, Bye, Harrison, Tsuyuki, & Shaw, 2014).  
According to Scahill and colleagues, administrators of community pharmacies face two key issues 
under these changing policy conditions (Scahill, Harrison, Carswell, & Shaw, 2010). First, the delivery 
of value to key stakeholders is important for health system sustainability. Value is a measurement of 
the relative quality and cost of a service or product. In health care, value should be measured in 
terms of patient health outcomes achieved per dollar spent to achieve those outcomes (Hennrikus, 
Waters, Virk , & Shah, 2012). Second, a level of financial sustainability is required when making 
changes to the way services are delivered in community pharmacy. Shifting from the reimbursement 
per dispensing model to the current funding model where pharmacy delivers a range of quality 
assured patient oriented services will require two significant changes. First, workflows will need to be 
re-engineered and staff trained accordingly. Second, adequate remuneration for services rendered to 
patients needs to be provided (Scahill, Harrison, Carswell, & Shaw, 2010).  
The purpose of this study is to elucidate whether community pharmacy is being remunerated fairly 
for cognitive services provided to patients who have been identified as having medication adherence 
difficulties under the Long Term Conditions medication adherence service (LTC). The study aims to 
employ Activity Based Management (ABM) tools such as Time Driven Activity Based Costing (TDABC) 
to conduct cost driver analysis and activity analysis of the LTC service in pharmacy (Hansen, Mowen, 
& Guan, 2009).  
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The study is of significant importance to stakeholders such as DHB funders and community pharmacy 
service providers as there is an absence of information about the true cost of providing the LTC 
service to patients. Accurate cost data inform the allocation of scarce resources, help health service 
providers understand revenue by service line, and better support clinical teams in driving efficiency 
and improving outcomes (Donovan, Hopkins, Kimmel, Koberna, & Monty, 2014).  No previous studies 
that have attempted to define the costs of LTC service provision in community pharmacy have been 
described.  
This report is structured in 4 parts.  
Part 1 begins with a literature review which discusses background information about the current 
CPSA and the LTC service. Once the context for the study has been set, a review of ABM methods 
such as TDABC is discussed. The literature review concludes with an analysis of the application of 
TDABC in healthcare settings to elucidate cost drivers and improve patient outcomes.   
Part 2 outlines the research methodology and research design applied to this study. 
Part 3 analyses the results gathered from the semi-structured survey. 
Part 4 concludes with a discussion of key findings, recommendations for management of the LTC 
service and limitations of the study. 
Part 1: Literature Review 
Background to the CPSA- Impetus for change 
Under the contractual arrangements with DHB’s prior to 2012, community pharmacies had been 
compensated according to the number of prescriptions they dispense (volume) and the frequency of 
those dispensings (PHARMAC, 2012). This meant that there had been an incentive for some 
pharmacies to encourage clinicians to stipulate more frequent dispensings1 on their scripts under the 
‘Close Control’ Pharmaceutical Schedule Rule2. The resulting expenditure growth in pharmacy 
dispensing costs had become unsustainable, and the linking of funding to volumes had little 
relationship with patient outcomes (Best Practice Journal, 2012). In 2010 the total cost of dispensing 
fees was $320 million, of which $82 million was spent on dispensing medicines under the Close 
                                                          
1
 The more frequent dispensing was previously known as “Close Control” and is now known as “Dispensing 
Frequency”. The Pharmaceutical Schedule specifies, for community patients, a default period of supply for each 
community Pharmaceutical. The Dispensing Frequency Rule defines patient groups or medicines eligible for 
more frequent dispensing periods for Community Pharmaceuticals; and the conditions that must be met to 
enable any pharmacy to claim for payment for the additional dispensings made (PHARMAC, 2015).  
2
  The Pharmaceutical Schedule is a list of approximately 2000 community pharmaceuticals that are subsidised 
by the government. It shows the amount of the government subsidy paid to contractors, as well as the 
manufacturer’s price and any access conditions that may apply (PHARMAC, 2015).  
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Control Pharmaceutical Schedule Rule1 (Best Practice Journal, 2012). The new CPSA removes the 
volume and frequency based incentives, and aims to reward patient based clinical care.  
The new funding model under the CPSA is designed to be patient-centred and allows pharmacists to 
better tailor medicines adherence and compliance services to patients, particularly those with 
multiple co-morbidities and taking many medicines (Best Practice Journal, 2012). It gives an incentive 
for the pharmacist to spend time providing cognitive services to patients requiring additional 
support. This includes the opportunity to work with the patient’s GP and clinicians in secondary care 
on reviewing and reconciling medications (Best Practice Journal, 2012). 
A closer look at the LTC service and its funding 
Under the current CPSA patients are classified as either core or LTC patients.  Only those patients 
who are assessed as having medicine adherence concerns can be considered for the LTC service 
(Central TAS, 2014).  Medication adherence has been recognised as a key factor in reaching 
successful clinical outcomes for chronic conditions (Marquis, Schneider, Spencer, Bugnon, & 
Pasquier, 2014). Its promotion is part of the quality standards for pharmaceutical services instituted 
jointly by the International Pharmaceutical Federation and the World Health Organisation, and 
community pharmacists have engaged in delivering medication adherence programmes in various 
countries (Marquis, Schneider, Spencer, Bugnon, & Pasquier, 2014).  
Implementing an adherence programme implies an important change in pharmacists’ vision of their 
position within the health system. It requires multidisciplinary collaboration and the development of 
a shared view of the role that pharmacists and physicians hold with regard to patient adherence and 
treatment management. This represents a long-term development for which the reorganisation of 
workloads, adjustments in human resources and the acquisition of novel skills are necessary 
(Marquis, Schneider, Spencer, Bugnon, & Pasquier, 2014). 
The eligibility of a patient to the LTC service is managed through the LTC Service Eligibility 
Assessment Tool, which sets a nationally consistent set of criteria for entry to the service (Central 
TAS, 2014).  Eligibility to the service is based on a pharmacist-led eligibility assessment which applies 
a standard set of agreed criteria. The assessment is used to identify factors that contribute to a 
patient’s adherence with their medicine regime and the actions that the pharmacist and the patient 
will work together to address the adherence issues.  Eligible patients will also benefit from the 
pharmacist working more closely with their prescriber to enhance the patient’s medication use and 
adherence of medicines. Pharmacist recommendations made to prescribers may also improve the 
clinical or cost effectiveness of treatment (Central TAS, 2014). Registered patients will be encouraged 
to use one pharmacy for dispensing, but may still receive medications from another pharmacy 
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(Central TAS, 2014).  A patient who was registered in the LTC Service but who no longer meets the 
eligibility criteria would be de-registered. 
All LTC patients registered with a pharmacy receive the following services (Central TAS, 2014):  
• Medicines Reconciliation3 
• Synchronization of medicines4 
• Medication Reminders 
• Ongoing screening and review of compliance/adherence & medicines alignment 
• Engagement with the patient’s multidisciplinary team members. 
 
Pharmacies only receive funding for those LTC Service patients registered with their pharmacy. 
Currently, community pharmacy gets paid $20.80 per month per registered patient5 (CentralTAS, 
2015). This payment covers only the services provided under the LTC service. Pharmacists receive a 
separate payment for medicine dispensing.   
 
The level of government funding for community pharmacy services is determined through the annual 
funding envelope which is the amount of funding that is available from DHBs for each financial year 
(District Health Boards, 2012). In 2012, the funding envelope was $370.5 million and the envelope is 
adjusted upwards every year by either 1.5% or contribution to cost pressure6 (whichever is lower). 
The funding envelope is determined on the basis of certain assumptions including population growth, 
demographic changes and prescription volumes which are monitored over the course of the funding 
year (District Health Boards, 2012). For the LTC service, the government funds the service based on 
an assumption that the number of registered patients would not exceed a pre-determined quantity 
(in 2012 this was 200,000 patients) (District Health Boards, 2012). Thus, the level of funding per 
patient for the LTC service is planned based on the level of funding available and the number of 
patients likely to benefit from the service, and not based on what it would likely cost pharmacists to 
deliver it.  
                                                          
3
 Medicine reconciliation services means,  collection (from all relevant prescribers), comparison and 
communication of the most accurate list of  medicines (Paton, et al., 2011) (Central TAS, 2014).  
4
 Medication synchronization involves pharmacists working with patients to coordinate refill of their 
medications to come due on a single day of the month (DiDonato, Vetter, Liu, May, & Hartwig, 2014) 
5
 The monthly fees was $20 prior to 1
st
 July 2015. The increase to $20.80 is in recognition of contribution to 
cost pressures (CCP) 
6
 Contribution to Cost Pressure or CCP means a percentage set by the Ministry of Health to assist in off-setting 
sectoral cost pressures including inflation and salary adjustments (District Health Boards, 2012).  
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The question of fair recompense 
Every health profession seeks recognition and compensation for its unique skills and contributions to 
the quality of a patient’s life (Schommer & Gaither, 2014). Community pharmacists are among the 
most accessible of healthcare professionals (Eades, Ferguson, & O'Carroll, 2011). Under the current 
CPSA, pharmacists provide clinical expertise regarding selection, handling, distribution and utilisation 
of medications and ensure medicines reach their full potential for patients in society. This implies a 
use of medications that is safe, effective, appropriate, affordable, cost-effective, efficient, and 
specific to the needs of a given patient (Schommer & Gaither, 2014).  
Community pharmacy owners in New Zealand are doubtful about the viability of CPSA, as there are 
many uncertainties in the funding arrangements (Sharma & Dousti, 2015). The concerns include; a 
lack of clear guidelines around the service expectations and funding for services, over-burdening 
pharmacists with administrative work and the compliance support work (Sharma & Dousti, 2015). In 
order for community pharmacists to find ways to improve value delivered to patients, they not only 
must know what it currently costs to do things, but they must also evaluate why and how they do 
things. There may be process differences between pharmacies delivering the services, which may 
translate to differences in cost and outcomes for patients based on the quality of services provided. 
Without information on the activities and processes that drive costs in pharmacy delivering the LTC 
service, funders and providers of health related services are unable to quantify any shortfalls in 
funding.  
The current study aims to shed light on these issues by employing cost accounting techniques to 
enable stakeholders in community pharmacy to understand what it costs to provide the LTC service 
to registered patients. Stakeholders may use this information to better understand the drivers of 
costs with the aim of standardising, streamlining and/or supplementing current processes. 
Policy makers refer to cost as the disbursements made to health care providers for delivering care 
(Kaplan & Porter, 2011). For providers, however, cost refers to the amounts they pay for staff, 
equipment, supplies, and facilities to deliver patient care (McLaughlin, et al., 2014). Cost, as used in 
the context of this study, is the cash or noncash assets sacrificed for goods and services that are 
expected to bring a current or future benefit to the organisation (Hansen, Mowen, & Guan, 2009, p. 
24). Information on costs and drivers will better enable community pharmacists to evaluate the 
services they provide to patients, examine the cost of care, reduce wasteful activities and the costs 
associated with them, and improve quality of care for patients (Donovan, Hopkins, Kimmel, Koberna, 
& Monty, 2014).  
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Activity Based Management 
Activity-based management (ABM) focuses on the management of activities with the objective of 
improving the value received by the customer and the income received by the organisation in 
providing this value (Hansen, Mowen, & Guan, 2009, p. 35). ABM draws on Activity Based Costing 
(ABC) as a major source of information. Activity-based costing (ABC) is a costing approach that 
assigns resource costs to a cost object based on activities performed for the cost object. A diagram 
that outlines the ABM model is illustrated in Figure 1.  
 
 
Figure 1 (above): The vertical dimension traces the cost of overhead resources to activities and then to the cost 
objects. This is the activity-based costing dimension (referred to as the cost view). It serves as an important 
input to the control dimension, which is called the process view. The process view identifies factors that cause 
an activity’s cost (explains why costs are incurred), assesses what work is done (identifies activities), and 
evaluates the work performed and the results achieved (how well the activity is performed). Activities play a 
prominent role in assigning costs to other cost objects and are essential elements of an activity-based 
management system. Figure 1 excerpt from (Hansen, Mowen, & Guan, 2009) 
 
Suitability of ABC as a predictor of cost 
 In conventional cost accounting systems used in healthcare settings such as pharmacy, direct costs 
are allocated directly to patients or the funding entity (Udpa, 1996). Indirect costs such as overheads, 
however, are accumulated and divided by the total number of patient days to give the cost per day 
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of maintaining operations. This can lead to distortions in estimating costs as some patients, such as 
the high needs LTC patients, may require more direct resources such as pharmacist time than core 
patients who require minimal pharmacist oversight. Hence, the conventional cost allocation systems 
provide inadequate transparency to guide health providers’ efforts to enhance processes and control 
costs (Kaplan, 2014). 
 
Since ABC provides greater visibility into organizational processes and their cost drivers, it may allow 
managers to eliminate costs related to non-value added activities and improve the efficiencies of 
existing processes (Demeerec, Stouthuysena, & Roodhooft, 2009). Some authors, however, have 
noted possible disadvantages with the use of ABC to determine costs.  Lievens and colleagues, for 
example, argue that a potential drawback of ABC systems lies in the time and resource consumption 
associated with the development and management of these systems (Lievens, Bogaert, & Kesteloot, 
2003). Kaplan and Anderson state that the high time and cost to estimate an ABC model and to 
sustain it – through re-interviews and re-surveys – has been a key barrier to widespread ABC system 
adoption (Kaplan & Anderson, 2004). Supporting this notion, Everaert and colleagues assert that 
several managers, including those in healthcare, who have tried to implement ABC in their 
organizations, have abandoned the attempt in the face of rising costs and employee irritation 
(Everaert, Bruggeman, & De Creus, 2008).  
 
To circumvent some drawbacks with the ABC system, Kaplan and Anderson have developed and 
described a simplified approach to ABC, called time driven activity based costing (TDABC) (Kaplan & 
Anderson, 2004). In the revised approach, managers directly estimate the resource demands 
imposed by each transaction, product, or customer rather than assign resource costs first to activities 
and then to products or customers. A TDABC model can be estimated and installed quickly and 
inexpensively as estimates of only two parameters are required: (1) the unit cost of supplying 
capacity and (2) the time required to perform a transaction or an activity (Demeerec, Stouthuysena, 
& Roodhooft, 2009). It is relatively easy for managers to update their TDABC models to reflect 
changes in operating conditions. For example, to add more activities to a department, managers 
don’t have to re interview personnel; they can simply estimate the unit time required for each new 
activity (Kaplan & Anderson, 2004). 
 
The use of TDABC systems in healthcare  
Kaplan and Porter attribute a large part of the rapid escalation in health care costs to the fact that 
providers have a scant understanding of how much it costs to deliver patient care (Kaplan & Porter, 
2011). This shortfall in understanding and associated knowledge of cost and its drivers results in an 
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inability of health providers to effectively improve resource utilization, reduce delays, and eliminate 
activities that don’t improve outcomes. Kaplan and Porter present TDABC as an effective and 
efficient tool for health professionals to accurately measure costs (Kaplan & Porter, 2011).  
 
Recently, TDABC has gained popularity in health economics as an accurate costing methodology that 
provides clinicians and staff with valid, actionable process and cost data to redesign care effectively 
(Hennrikus, Waters, Virk , & Shah, 2012).  TDABC estimates, from the provider’s perspective, the cost 
of each resource used for treating a patient’s medical condition and combines it with the time each 
resource uses for each activity during a patient’s care (McLaughlin, et al., 2014).  All of these 
activities can then be added together to measure the total cost of an entire service or care episode.  
 
There have been numerous studies that have attempted to better define costs of delivering 
healthcare using TDABC (Donovan, Hopkins, Kimmel, Koberna, & Monty, 2014) (Demeerec, 
Stouthuysena, & Roodhooft, 2009) (Hennrikus, Waters, Virk , & Shah, 2012). For example, the 
Cleveland Clinic7 reported that the use of TDABC system resulted in significant enhancements to the 
clinical and administrative processes for the cost objects studied, and reductions in expenses related 
to direct administrative and support processes for these cost objects (Donovan, Hopkins, Kimmel, 
Koberna, & Monty, 2014). Cleveland clinic claims that these administrative and support processes 
represent 6 to 7 percent of the total cost of an episode of care for patients undergoing a specific 
surgical procedure (Donovan, Hopkins, Kimmel, Koberna, & Monty, 2014). 
Conclusion 
The literature review furnishes background information about the current CPSA and the LTC service. 
The CPSA aims to be more patient-centric and utilises the professional capacity of community 
pharmacists. Despite the intent of the CPSA to provide community pharmacists with a greater role in 
providing patients with enhanced services, an indication of its reasonableness and fairness, in terms 
of remuneration for services provided, has not been explored. Such examination hasn’t taken place 
even though community pharmacy has signalled a shortfall in funding.  
 
A review of the literature indicates ABM methods, such as TDABC, have been successfully employed 
in healthcare settings to determine costs and improve processes. The current study aims to employ 
the TDABC system to the community pharmacy LTC service with the objective of better 
understanding the activities and cost drivers that underlie the service.  It is hoped that the study will 
                                                          
7
 The Cleveland Clinic is a non for profit multispecialty academic hospital located in Cleveland, Ohio (Cleaveland 
Clinic, 2015)   
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lay foundation for further research that could study the cost drivers of other government funded 
programs in pharmacy with the intent of defining cost drivers and improving processes to deliver 
more cost-effective outcomes based care for patients.  
 
This study aims to define the actual cost to pharmacy of delivering the LTC service through the lens 
of Activity Based Management (ABM) and define the processes and activities that drive these costs 
using a time driven activity based costing system (TDABC). A review of the literature indicates ABM 
methods, such as TDABC, have been successfully employed in healthcare settings to determine costs 
and improve processes. 
At the conclusion of this study, it is hoped that stakeholders in community pharmacy will better 
understand what it costs to provide the LTC service to patients.  
Part 2: Research Methodology 
 
The research methodology outlines the methods by which data that support the objectives of the 
paper were collected, organised and analysed.  
Research Design (Data collection) 
Data for this study was collected through a semi-structured survey. The survey responses informed a 
TDABC analysis of the cost of providing the LTC service in pharmacy.  
 
To carry out a TDABC analysis, the hourly cost rate of each resource that contributes to a specific 
patient’s care is multiplied by the amount of time each resource spends contributing to that patient’s 
care (Hennrikus, Waters, Virk , & Shah, 2012). The total cost of all contributing resources can then be 
summed in order to calculate the cost of providing the service to the patient. This is the basic 
approach that the study undertook to calculate the costs of delivering the LTC service.  
 
It should be noted that the long term conditions that pharmacists provide support and services for 
include a wide range of ailments8. Collecting and analysing data for all these various ailments would 
be inefficient, as there are different patient needs for each ailment, and thus a different contribution 
of the pharmacist resource for a specific condition.  To overcome this, the study focuses on one LTC 
condition, namely, diabetes. Diabetes was chosen as it is an important health target area for the 
Ministry of Health (Ministry of Health, 2014). Diabetes is a common chronic disease with significant 
                                                          
8
 These include diabetes, cardiovascular disease, cancer, asthma and dementia (Central TAS, 2014) 
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morbidity, mortality and cost, and the prevalence continues to increase rapidly worldwide (Coppell , 
et al., 2013).  
 
There are various means of collecting the time each resource in pharmacy spends in supporting and 
servicing a diabetes patient.  Interviews, questionnaires, surveys, and observation are common 
means of gathering primary data for an activity based costing system (Hansen, Mowen, & Guan, 
2009). The intent of this study is to employ as many pharmacy sites as possible (minimum 9) to 
enable a significant sample size to be established and reduce variability between pharmacies. To that 
end, the data gathering methodology that the research employed is a standardised and semi-
structured questionnaire. Through this means, the study aimed to employ a greater number of 
pharmacy sites, rather than be constrained for resources through direct observation or interviews at 
multiple sites spanning New Zealand.  
Survey Design 
The survey consisted of three sections, namely, participant profile, LTC cost profile and pharmacy 
profile. A copy of the survey sheet is available in Appendix 1.  
Participant Profile  
The participant profile was open-ended and gathered information about the number of years the 
respondent has been a practicing pharmacist. As this is an anonymous survey, no participant names 
were elicited. The survey was restricted to registered pharmacists. 
LTC cost profile  
This section is designed to gauge how long the pharmacist spends delivering the LTC service to a 
typical diabetes patient in each calendar month. This included the pharmacists’ time in the absence 
of the patient in the pharmacy and/or with the patient’s extended care team including their GP or 
specialist prescriber. Values were measured in minutes. The section also collected information about 
the number of LTC patients registered with the pharmacy. This part of the survey was open ended 
and approximate time values were acceptable.  
The design of the survey questions in this section incorporated the guidelines developed by the DHBs 
to assist pharmacists to deliver the LTC service (Central TAS, 2014).  
Servicing a diabetic LTC patient involves three separate workflows which comprise a number of 
activities: 
1. Setting up a diabetic as an LTC patient 
 Discussing the service and gaining patient consent 
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 Assessing the patient using pharmacy data (patient history) 
 Contacting the patients other health providers 
 Preparing an initial Medicines Management Plan (MMP) 
 Discussing the MMP with the patient and gaining agreement to work together to 
improve their adherence 
2. Starting up the service for the LTC patient 
 Explaining current medicines to the patient 
 Medicines Synchronisation 
 Medicines Reconciliation 
 Setting up a reminder service 
3. Ongoing monthly support for the LTC patient 
 Medicines Synchronisation 
 Medicines Reconciliation 
 Reminders 
 Interaction with multidisciplinary team, including information sharing 
 Recording interaction with the patient 
 Review of the MMP 
 
Survey respondents were asked to enter the approximate time taken (in minutes) to complete the 
activities above and indicate the staff member who mainly carries out these activities (i.e. pharmacist 
or technician). Respondents were given the opportunity to define any additional activities they 
perform when servicing the patient and the time taken to do so. Direct costs were elicited in a 
separate question.  
The LTC cost profile questions were assessed by a registered pharmacist from the Pharmacy Guild of 
New Zealand9 (PGNZ) to ensure they accurately represented the workflows in pharmacy.  
Pharmacy Profile 
This section collected information that identified the size, location and demographic profile of the 
pharmacy.   
This includes information about the: 
 Number of prescription items dispensed each week (open ended) 
                                                          
9
 The Pharmacy Guild of New Zealand is a national membership organisation representing roughly 70% of 
community pharmacy owners (Pharmacy Guild of New Zealand (Inc.), 2015) 
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 Geographic location of the pharmacy (coded multiple choice question)  
 Region in which the pharmacy is located (coded multiple choice question) 
 Setting of the pharmacy10 (coded multiple choice question) 
 Number of hours the pharmacy operates each week (open ended) 
  
This information is useful as it enables the researcher to be informed about the context within which 
the pharmacy operates and if there are any external factors that could influence cost of delivering 
the LTC service. Take for example a pharmacy located in a region with a high incidence of diabetes as 
compared to a region where diabetes has a low prevalence. One would expect the pharmacy in the 
area with a higher burden of diabetes to have more patients enrolled who have the ailment as 
compared to the pharmacy in an area with a lower burden of the ailment. One may assume the 
pharmacy serving a higher number of patients may spend different levels of time per patient as 
compared to the pharmacy that does not service as many patients. The pharmacy servicing a higher 
proportion of diabetes patients may have established processes to ensure that the diabetes patient is 
receiving the required levels of service in an efficient way. This presents the researcher with an 
opportunity to distinguish any differences in activities and the resources driving costs in both types 
of pharmacies.  
Data Analysis and TDABC 
The information derived from the survey questions served as the basis to assign resource costs to 
individual activities. The cost of the resource11 time was approximated via the capacity cost rate. 
Capacity cost rate is the annual total cost of the resource (including salary/benefits) divided by the 
available time the resource has (Kaplan, Introduction to Time-Driven Activity-Based Costing in Health 
Care, 2014).  The capacity cost rate is then multiplied by the total time the resource spends servicing 
the LTC patient per month. This cost is then added to any monthly consumable allocation to arrive at 
the cost per patient per month.  The cost per patient per month at one site will then be compared 
against the other survey sites to deduce an average cost per LTC patient.  
 
Table 1 illustrates how the data collected from the survey informed approximations for the cost of 
providing services to LTC patients. The numbers and values quoted in the table are theoretical and 
are included for explanatory purposes only.  
 
                                                          
10
 This would involve finding out if the pharmacy is located at a mall, by a medical centre or on a main street.  
11
 Resources include employees and all other assets used in servicing the patient (including software and 
occupancy costs). Occupancy costs include rent, rates and electricity.  
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Table 1 shows that the capacity costs for all resources are approximated and multiplied by the time these 
resources are required to complete various activities. These resource costs are then added to any direct costs 
that may be incurred to give the total monthly cost of servicing a particular patient.  Note that in addition to 
ongoing monthly costs, the pharmacy incurs a one-off cost in setting up and starting up the service for the LTC 
patient. 
Pharmacist and technician remuneration was determined through a PGNZ remuneration survey 
(Pharmacy Guild of New Zealand (Inc), 2014). Software rates were determined through personal 
communication with software vendors. Capacity cost rate for occupancy costs was determined 
through a benchmarking survey by Moore Stephen Markhams (Moore Stephens Markhams, 2014).   
Research Plan 
The researcher enlisted the assistance of PGNZ for dissemination of surveys to participants. The 
survey was communicated to members of PGNZ through a weekly ‘Guild in Touch’ email newsletter. 
A web link to the survey was included in the newsletter. The web link to the survey document 
included information regarding: 
 The nature and purpose of the research 
 The proposed use of the material collected 
 Confidentiality of the data and the anonymous nature of the data collection 
 Restriction on who may access the data 
 Method and timing of data destruction 
Activities in 
servicing a 
diabetic LTC 
patient
Capacity cost 
rate per 
minute of 
pharmacist 
time
Capacity cost 
rate per 
minute of 
technician 
time
Capacity 
cost rate per 
minute of 
software 
use
Capacity cost 
rate per 
minute of 
occupancy 
time
Unit time in 
minutes(pharmacist)
Unit time in 
minutes 
(technician)
Unit time in 
minutes(software)
Unit time in 
minutes(occupancy)
Total 
Rate
Setting up 
Service 0.71$                  0.35$               0.02$             0.06$                15 10 10 15 15.25$ 
Starting up 
Service 0.71$                  0.35$               0.02$             0.06$                12 5 5 12 11.09$ 
Monthly 
Support 0.71$                  0.35$               0.02$             0.06$                25 10 15 15 22.45$ 
26.34$ 
22.45$ 
Consumable costs 2.50$                  
24.95$                             
Direct costs per month
Table 1: An illustration of TDABC analysis following collection of data from the survey
Total one-off cost
Total monthly ongoing cost
Total Monthly Cost of providing service to a diabetic LTC patient
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Part 3: Results 
Demographic profile of respondents 
18 pharmacies responded to the survey. Table 2 shows the respondent pharmacies by geographic 
location, Table 3 outlines the respondent pharmacies by region and Table 4 summarises the 
respondent pharmacies by setting.  
Table 2: Responding pharmacies by geographical location 
Geographical Location Count of Survey Site % 
Major City 5 28% 
Provincial city 5 28% 
Town/Rural 8 44% 
Grand Total 18 100% 
 
Table 3: Responding pharmacies by region 
Region  Count of Survey Site % 
Auckland 2 11% 
Bay of plenty 1 6% 
Canterbury 4 22% 
Hawkes bay 1 6% 
Nelson  2 11% 
Taranaki 2 11% 
Waikato 2 11% 
Wellington 4 22% 
Grand Total 18 100% 
 
Table 4: Responding pharmacies by setting 
Pharmacy Setting Count of Survey Site % 
Main street 8 44% 
Mall 1 6% 
Medical centre 9 50% 
Grand Total 18 100% 
 
TDABC analysis 
TDABC analysis was carried out by identifying the capacity of each resource and allocating the cost of 
this capacity over the cost object based on the time required to perform the activity to service an LTC 
patient (Monroy, Nasiri , & Peláez, 2012). The cost of resource capacity is referred to as the capacity 
cost rate (Kaplan & Anderson, 2004). Table 5 shows the capacity cost rates that were used in the 
analysis. 
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Table 5: Capacity cost rates used in the TDABC analysis 
Labour rates 
Geographical 
Location 
Pharmacist (per minute) Technician (per minute) 
Major City $0.58 $0.37 
Provincial city $0.62 $0.37 
Town/Rural $0.62 $0.36 
Software Rates 
Per week (average) $84.60 
Occupancy Rates (per week- average) 
Auckland Mall $2,115.38 
Auckland Medical 
Centre $1,500.00 
Auckland Street $1,384.62 
City Mall $1,461.54 
City Medial Centre $1,384.62 
City Street/Town $1,153.85 
Rural  $692.31 
Table 5: Capacity cost rates for labour were determined through a PGNZ remuneration survey (Pharmacy Guild 
of New Zealand (Inc), 2014). Software rates were determined through personal communication with software 
vendors. Capacity cost rate for occupancy costs was determined through a benchmarking survey by Moore 
Stephen Markhams (Moore Stephens Markhams, 2014).  Per minute cost rate for software and occupancy was 
calculated based on the operating hours of the pharmacy per week.  
The cost of service was calculated as described in Table 1. The capacity cost rate per resource was 
multiplied by the time the resource was used in servicing the LTC patient. These resource costs were 
then added to any direct costs that were incurred to give the total one-off and ongoing cost of 
servicing a patient.   
Analysis of survey responses  
Statistical analysis and margin of error 
A summary of statistical analysis on the survey data is presented in Table 6. The margin of error for a 
sample of 18 respondents out of a population of 97012 pharmacies and a confidence interval of 95% 
was determined by a sample size calculator developed by Raosoft (Raosoft Inc, 2004). The margin of 
                                                          
12
 Number of community pharmacies in New Zealand as at 1
st
 October 2015 (population size) determined from 
a database owned by PGNZ 
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error (assuming normal distribution) is 23%. This means that the researcher is 95% confident that the 
values presented in Table 6 lie between an interval of ±23% around the average value (Silver, 1992). 
To enable a more representative sample with a confidence level of 95% and a margin of error of 5%, 
276 respondents would be required.   
Table 6: A summary of statistical analysis on survey responses. 
Survey Site 
Responses 
Average 
(Mean) 
Minimum Lower 
Quartile 
Median Upper 
Quartile 
Maximum Standard 
Deviation 
Years Practiced 21 3 10 22 30 40 12 
Number of LTC 
patients 
Registered 
357 25 128 202 273 505 149 
Weekly 
Dispensings 
1943 450 1400 2000 2500 4200 934 
Hours of 
Operation 
52 40 46 49 52 84 10 
One off set up 
costs 
$76.56 ± 
$17.61 
$4.24 $55.69 $77.49 $99.31 $132.92 30.9 
Ongoing 
monthly costs 
$50.13 ± 
$11.53 
$10.67 $25.52 $41.93 $79.40 $102.68 31.0 
Table 6 shows statistical analysis of the survey responses received from 18 pharmacy sites. In addition to 
ongoing monthly costs, pharmacies incur a one-off set up cost to initiate the patient for the LTC service. 
Assuming a margin of error of 23%; the average one off set up costs lie between $58.95 and $94.17. Average 
monthly costs lie between $38.60 and $61.66. Results indicate that, on average, pharmacies are underpaid for 
the service by about $29 per month. In addition, pharmacies incur about $76 on average as a one-off cost. This 
means a pharmacy would have to service an LTC patient for 4 months before fully recovering one-off costs. 
Interestingly, minimum values suggest that some pharmacies are able to service the patient well below the 
$20.80 threshold. While the small sample size may mean that this could be due to respondent or sampling bias, 
further study into pharmacies with a low cost profile could yield insights into the low cost results. High 
dispersion (standard deviation) around the average is observed for the number of LTC patients registered and 
the number of weekly dispensings.   
Patients who have chronic conditions and are registered under the LTC service usually receive 
frequent repeat dispensings of medicine (Central TAS, 2014). One would expect a pharmacy with a 
higher number of LTC patients registered to have greater number of weekly dispensings relative to a 
pharmacy that has very few LTC patients registered. To test the data, the number of weekly 
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Figure 3: Location of pharmacy and cost of service 
Average ongoing
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Average  one-off set
up costs
dispensings was plotted against the number of LTC patients registered. The result of this analysis, 
shown in Figure 2, shows a positive association between the two variables as expected.  
Figure 2 shows a positive relationship between weekly dispensings and the number of LTC patients registered.  
Cost profile by Demographic 
The cost of providing the LTC service can be further examined through the average one-off and 
ongoing costs in the various demographic areas. Figure 3 shows the survey responses for cost of 
providing the service at different locations. Figure 4 outlines the responses for cost of providing the 
service in the various regions. Figure 5 illustrates the responses for the cost of providing the service 
at different settings.  
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Figure 2: Relationship between weekly dispensing and number of patients 
registered 
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Figure 3 shows major cities, on average, attract higher ongoing and one-off set up costs as compared to other 
locations. This result may be attributable to higher costs for occupancy costs in such locations. Provincial cities 
seem to have the lowest ongoing and one-off costs. These areas may attract less rental rates than major cities 
and are usually operational for a longer time than pharmacies in rural locations (thus being able to have less 
capacity cost rates for cost drivers such as rent).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Highest ongoing and one-off costs seem to centre on the Bay of Plenty. One may assume that these 
costs could the result of higher cost drivers such as occupancy costs or staff costs. While Nelson shows the 
lowest average ongoing costs, the Hawkes bay region presents the lowest one-off set up costs. These results 
indicate that costs levels may not be directly attributable to any one region. Without a larger sample size and 
information about demographic factors that could contribute to service costs (such as a population with 
greater health needs), conclusions about cost profiles in regions may not be accurate.   
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Figure 5: Mall setting shows the lowest one-off and ongoing costs. However, there was only one respondent 
from such a setting. Conclusions about setting versus costs may thus be influenced by sampling bias. However, 
one may theorise that lower cost in malls may be attributable to their longer operating hours (thus having 
lower capacity cost rates for occupancy). A greater sample size would yield more reliable results for costs at 
such settings.   
Determinants of cost drivers 
Having established an estimate of the cost of providing the service through TDABC, the drivers and 
determinants of cost were analysed. The purpose of the analysis is to determine which variable 
contributes most significantly to costs. With this information, stakeholders in community pharmacy 
may consider determinants of cost with the objective of managing them closely.  
The variables analysed were: 
1. Resource cost drivers (Figure 6) 
2. One off costs in relation to ongoing costs (Figure 7) 
3. Weekly dispensings versus cost of service (Figure 8) 
4. LTC registrations versus cost of service (Figure 9) 
5. Level of pharmacist experience versus cost of service (Figure 10) 
 
In addition to the above, a multiple regression analysis was carried out on weekly dispensings, LTC 
registrations and level of pharmacist experience to determine which variable has the strongest 
relationship to on-going and one-off costs.  
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Figure 5: Cost of service at various pharmacy settings 
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Figure 6 plots cost drivers against the ongoing monthly costs and one off costs. It is observed that labour costs 
for the pharmacist is the major factor in driving costs. Direct and software costs contributed the least towards 
cost.  Cost savings could thus focus on streamlining or improving the process for patient pharmacist contact 
and consultation. A greater focus on software support tools for servicing LTC patients may improve efficiency 
and allow pharmacists to free up time when the pharmacy is facing increased workloads. 
Figure 7: One off costs were plotted against on-going costs to determine relationship. The regression trend line 
suggests that there is a relative degree of positive linear relationship between one-off costs and ongoing costs. 
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Figure 6: Comparison of cost drivers (average values) 
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Perhaps, pharmacists who invest time and effort into servicing the patient also invest time and effort for the 
on-going care of the patient. Further analysis could focus on high cost and low cost pharmacies to determine 
where process differences lie with the aim of improving efficiencies. Such analysis should ensure effectiveness 
in terms of clinical outcomes for the patient and patient safety are not compromised.  Figure 6 also shows that 
a majority (83.3%) of pharmacy respondent costs lie above the red horizontal line (which denotes the current 
$20.80 monthly payment per registered patient). This further illustrates that the current funding for this LTC 
service falls below the costs incurred by 5/6
th
 of the survey sample.  
 
Figure 8: Number of LTC registrations plotted against the average ongoing and average one-off costs to 
determine relationship. The regression trendline suggests a weak positive relationship between the variables. 
This result indicates that costs may not be solely attributable to the number of LTC patients registered. 
R² = 0.01 
R² = 0.03 
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Figure 9: Weekly dispensing plotted against the average ongoing and average one-off costs to determine 
relationship. The regression trendline suggests a weak positive relationship between the variables. This result 
indicates that costs may not be only attributable to the number of LTC patients registered. 
 
Figure 9: Number of years pharmacist experience plotted against the average ongoing and average one-off 
costs to determine relationship. The regression trend line suggests a weak negative relationship between the 
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variables. This result indicates that costs may not be absolutely attributable to the number of years of 
pharmacist experience.  
 
Multiple regression analysis 
There are multiple factors that could contribute to the cost of servicing a patient and this report has 
conducted regression analysis on independent variables13 to determine whether there is any 
significant relationship between costs and the variables studied. A multiple regression analysis can be 
used to identify relationships between a variable such as cost and multiple independent variables to 
determine the factor that is most significant (Silver, 1992). To that end, a multiple regression analysis 
was undertaken between costs (on-going and one-off), number of LTC registrations, weekly 
dispensings and pharmacist experience. Through the analysis, one may determine which factor has 
the most impact on the cost of service.  
Multiple regression analysis was conducted using the LINEST (line statistics) function in Microsoft 
Excel 2010 (Microsoft, 2015). The results of the analysis are outlined in Table 7.  
Table 7: Results of LINEST multiple regression analysis 
One Off set up costs 
Slope: Years practiced as a Pharmacist -0.67 
Slope: Number of LTC patients Registered 0.07 
Slope: Weekly Dispensings -0.01 
Average one off set up cost (Y-intercept) $90 
Standard Deviation 28.5 
Ongoing monthly costs 
Slope: Years practiced as a Pharmacist -0.41 
Slope: Number of LTC patients Registered 0.03 
Slope: Weekly Dispensings -0.01 
Average one off set up cost (Y-intercept) $59.5 
Standard Deviation 24.4 
Table 7 shows that pharmacist experience is the most significant factor in determining both one-off and 
ongoing monthly costs. Every additional year of pharmacist experience lowers one off costs and ongoing 
monthly costs by $0.67 and $0.41 respectively. It is also noted that on average, every additional LTC patient 
registered increases cost for one off costs and ongoing costs by $0.07 and $0.03 respectively.  The multiple 
regressions show that the one off cost per patient is $90 with deviation of 28.49. For ongoing costs it is $59.50 
per month with deviation of 24.4. This result is consistent with the average values for cost (with margin of 
error) outlined in Table 6. This result further consolidates the finding that the cost of providing the service 
exceeds the remuneration provided to pharmacies by the DHBs.  
                                                          
13
 The independent variables are Number of LTC patients registered, weekly dispensings and pharmacist 
experience 
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Caution should be exercised when drawing conclusions from the multiple regression results in Table 
7 due to the small sample size. Conceptually, one may surmise that experienced pharmacists have 
broader clinical understanding and have familiarity with patients presenting at their pharmacy. 
Although it may not be accurate to exclaim that greater pharmacist experience reduces LTC service 
costs, it gives stakeholders the opportunity to further examine processual variations between 
beginner and experienced pharmacists that may explain differences in efficiencies.  In a similar 
fashion, the results presented here enable stakeholders to understand the cost drivers that add to 
costs for every additional LTC patient registered. One may assume that such an observation arises 
due to the administrative tasks that need to be completed for every registered LTC patient. This 
observation is at odds with the notion that greater specialisation (due to increased number of 
patients) would lead to lower costs. It should be noted, however, that LTC patients present at the 
pharmacy at random times. It could be that patients may present at times when the pharmacy is 
busy, thereby increasing the opportunity cost of servicing the patient.  
Part 4: Discussion and conclusion 
 
The purpose of this report is to inform stakeholders in community pharmacy about the costs of 
providing the LTC service. No other studies have attempted to define these costs. Stakeholders may 
use this information to better understand the drivers of costs with the aim of standardising, 
streamlining and/or supplementing current processes. The report collected primary data through a 
semi-structured survey instrument and 18 responses were elicited from participating pharmacies. 
TDABC was employed to estimate the cost of providing the LTC service.  
 
The objective of the discussion is to: 
 Outline key findings and suggest recommendations  
 Address research constraints 
 Consider the suitability of TDABC as a costing tool in the context of this study 
 
Key Findings and recommendations  
Cost of delivering the service 
Results suggest that the monthly payment of $20.80 per diabetes LTC patient registered is 
insufficient to cover ongoing costs. In addition to ongoing costs, pharmacies incur one-off costs to 
initiate a new patient into the LTC service.  One-off costs and ongoing costs seem to have a positive 
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co-relation. The average ongoing costs were estimated as $50 per month with a lower quartile of 
$25.50 and an upper quartile of $79. Assuming an LTC patient is registered for a year, pharmacies 
incur between $306 - $948 per annum as ongoing costs. Average one off costs were estimated at $77 
with a lower quartile of $56 and an upper quartile of $99. A majority of annual costs can be assigned 
to ongoing costs which show considerable variation between pharmacies. Further work in this area 
should focus on understanding process variations in these low-cost and high cost areas which 
contribute to differences in costs.  
Pharmacist experience and cost  
Pharmacist experience was the variable with the greatest effect on one-off and ongoing costs. 
Experienced pharmacists seem to be able to service patients in a more cost-effective manner. This is 
not surprising given experienced pharmacists have had greater exposure with patients who have high 
health needs. Further studies could examine process differences that experienced and beginner 
pharmacists employ with the aim of defining standard operating procedures or clear guidelines for 
delivering the service.  
Cost Drivers 
Labour cost rates for the pharmacist was the major driver of costs. Direct patient contact, liaison with 
the extended care team, medicines planning and administrative tasks require significant labour 
capacity. Stakeholders could consider additional software support that could automate patient 
eligibility and assist with administrative activities. Software has the least capacity cost rate and could 
thus be further utilised to streamline the LTC service and free up pharmacist time.  
Research constraints 
The determinations of this report should be considered in light of its limitations, which may offer 
several opportunities for further research. These limitations are outlined below.  
 A major constraint of this study was the small sample size contributing a 23% margin of 
error. Future studies should consider employing at least 276 respondent sites to limit the 
margin of error to 5% (with a confidence level of 95%). 
 Labour costs and overheads such as occupancy and software costs were estimated through 
secondary data sources. Further research could consider gathering pharmacy specific data 
for these costs to ensure greater precision.  
 LTC cost profile was estimated for diabetic patients only. Patients presenting with multiple 
chronic conditions or mental health issues may require more time with the pharmacist and 
require greater cost to service. Similarly, patients with better control of their condition may 
require less pharmacist support and require less cost to service. Future work could examine 
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the cost of providing the LTC service across a range of LTC eligible ailments. This would give 
stakeholders the opportunity to identify the LTC conditions that require greater pharmacist 
contact and support thereby adjusting remuneration to reflect the resources required by 
pharmacists to deliver care.  
Suitability of TDABC as determinant for costs 
As discussed in the literature review, TDABC has been employed successfully in various healthcare 
settings. While the TDABC technique has been lauded for its strengths14 in estimating costs due to its 
ease of implementation, it also has its limitations (Kowsari, 2013). The limitations of the TDABC 
technique in the context of this study are discussed below. Recommendations for alleviating 
limitations of the technique are also addressed.  
Limitations of the TDABC technique 
Inaccuracies in time estimations by survey respondents mean that there could be basic errors in the 
calculation of cost. Furthermore, the LTC service is variable in that some patients may take a few 
minutes to service while others may take much longer15. Variability in cost drivers also arises when 
there are tasks that either the pharmacist or the pharmacy technician can undertake depending on 
availability. These variabilities could be mitigated through time-in-motion studies where time 
estimates are gathered through direct observation. Multiple time observations would need to be 
gathered for survey sites to reduce variability. While this method is timely to research and 
implement, it should provide more reliable estimates for the time required for cost resources using 
TDABC.  
Conclusion 
This study demonstrates suitability of the TDABC methodology to estimate costs in healthcare 
settings such as community pharmacy. The findings of this study suggest that community pharmacy 
is underpaid for services provided to registered LTC patients. There is significant deviation in costs of 
delivering the service which opens an opportunity for closer assessment of activities that drive these 
variations. Greater utilisation of software through automation of patient eligibility and administrative 
tasks could help free up pharmacist time. It is hoped that this study will lay foundation for further 
research that could study the cost drivers of other government funded programs in community 
pharmacy with the intent of defining cost drivers and improving processes to deliver more cost-
effective outcomes based care for patients. 
                                                          
14
 The strengths of TDABC have been addressed in the literature review 
15
 Variability could stem from LTC patients having different level of health needs and varying levels of health 
literacy.  
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Appendix 1: Copy of survey questions 
 
 
 
An Activity Based Management study of LTC service provision in community pharmacy 
Researcher: Utsav Sharma, Victoria School of Management, Victoria University of Wellington 
Survey Sheet 
September 2015 
Participant Profile     (To be completed by a registered Pharmacist) 
Question 1: How many years have you practised as a Community Pharmacist?  
 
Long Term Conditions (LTC) specific questions 
Question 2: What is the total number of LTC patients registered with your pharmacy? 
 
The following questions are designed to gauge how long you spend delivering the LTC service to a 
typical Diabetes patient in each calendar month. Please consider all of your time spent in servicing 
the patient. This would include your time when the patient is not in the pharmacy and time you 
spend with the patient, their family and their extended care team including their GP or specialist. 
Please enter approximate values in minutes to the questions below. Please also indicate the position 
of the staff member who mainly carries out these activities.  
 
Question 3: Setting up a diabetic as an LTC patient 
 Discussing the service and gaining consent 
                       Time taken: ______                     Completed by: Pharmacist / Technician (Please circle the 
option that best applies) 
 Assessing the patient using pharmacy data (patient history) 
                       Time taken: ______                     Completed by: Pharmacist / Technician 
 Contacting the patient’s other health providers (e.g. GP) 
                       Time taken: ______                     Completed by: Pharmacist / Technician 
 Preparing an initial Medicines Management Plan (MMP) 
                       Time taken: ______                     Completed by: Pharmacist / Technician 
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 Discussing the MMP with the patient and gaining agreement to work together to improve 
their adherence 
                       Time taken: ______                      Completed by: Pharmacist / Technician 
 Anything else that you do to set up the patient for the LTC service? 
 Please describe:  
                      Time taken: ______                           Completed by: Pharmacist / Technician 
 
Question 4: Starting up the service for the LTC patient 
 Explaining current medicines to the patient 
                       Time taken: ______                          Completed by: Pharmacist / Technician 
 Medicines Synchronisation 
                      Time taken: ______                           Completed by: Pharmacist / Technician 
 Medicines Reconciliation 
                      Time taken: ______                           Completed by: Pharmacist / Technician 
 Setting up a reminder service (eg phone calls, txt messages, emails, stickers) 
                      Time taken: ______                            Completed by: Pharmacist / Technician 
 
Question 5: Ongoing monthly support for the LTC patient 
 Medicines Synchronisation 
                           Time taken: ______                           Completed by: Pharmacist / Technician 
On average how often? (eg once in 3 months, once a year?) 
___________ 
 Medicines Reconciliation  
                           Time taken: ______                             Completed by: Pharmacist / Technician 
On average how often?  
___________ 
 Reminders 
               Average time taken per month: ______        Completed by: Pharmacist / Technician 
 Interaction with the multidisciplinary team including information sharing 
                Average time taken per month: ______             Completed by: Pharmacist / Technician 
 Recording your interaction with the patient when dispensing medicines or providing 
reminders and interventions 
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                Average time taken per month: ______              Completed by: Pharmacist / Technician 
 Review of the MMP 
                Average time taken per month: ______               Completed by: Pharmacist / Technician 
 
Question 6: Are there any other actions or activities you provide as part of delivering the LTC service? 
If so, please describe the activity, the approximate time taken to complete the activity the frequency 
of the activity, and the position of the staff member who mainly performs the activity. The frequency 
describes how often you carry out the activity for the LTC patient. For example, the frequency could 
be annual for review of the patient and their MMP or quarterly for arranging prescriptions with the 
GP.  
Activity 
Time Spent 
(minutes) 
Frequency  Completed by 
(Pharmacist/Technician) 
    
    
    
 
Question 7: Are there any other costs you incur for a typical LTC diabetes patient that need to be 
covered by the LTC service fee? If so, please list these item(s) and the approximate value here. These 
would include direct costs not chargeable to the patient. Examples of direct costs are printed handouts 
and reminder stickers. (Please do not include things that are on charged to the patient like blister 
packs).  
Item Description Value ($)  Frequency 
   
   
   
 
Thank you for your responses to the LTC questions.  
Please could you answer the following questions so we can understand your pharmacy better? 
 
Pharmacy Profile 
Question 8: Which one of the following best describes the geographical location of this pharmacy? 
(Please tick the option that best applies) 
o Major City (e.g. Auckland, Wellington, Christchurch) 
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o Provincial City (urban area with a population over 30,000 people e.g. Hamilton, Dunedin, 
Nelson, New Plymouth, Napier, Gisborne etc.) 
o Provincial Town (town with a population between 1,000 and 30,000 people e.g. Levin, Gore) 
o Rural (non-urban areas such as rural centres with population under 1,000 people) 
 
Question 9: Which describes the setting of this pharmacy? (Tick as many as apply)   
o Within a medical centre  
o By a medical centre   
o Within a mall 
o By a hospital   
o On a main street shopping strip  
o Other (please specify) …………………………………………………… 
Question 10: Which DHB is the pharmacy located in (Please tick):  
o Auckland (Greater Auckland area including ADHB, WDHB and CMDHB) 
o Bay of Plenty 
o Canterbury (Including SCDHB) 
o Hawke's Bay 
o Lakes 
o Mid-Central 
o Nelson Marlborough 
o Northland 
o Southern 
o Taranaki 
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o Tairawhiti 
o Waikato 
o Wairarapa 
o Wellington (Including HVDHB and CCDHB) 
o West Coast 
o Whanganui 
 
Question 11: On average, how many prescriptions does the pharmacy dispense each week?   
………………………………………………. 
Question 12: How many hours is your pharmacy open each week? 
…………………………… 
Thank you for your participation in the survey. All information contained within the survey is 
confidential and anonymous. At the end of the research project, the hard copies of respondent 
surveys will be destroyed.  
If you would like a summary of the research findings please enter your email here: 
…………………………………………………………. 
 
If you have any questions or would like to receive further information about the research project 
and/or this survey , please contact Utsav Sharma at sharmautsa@myvuw.ac.nz or phone 04 802 8218 
 
